Stock 4552 JCR PHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus JCR Pharmaceuticals Co., Ltd.

Equities

4552

JP3701000006

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-21 am EDT 		5-day change 1st Jan Change
619 JPY -2.67% Intraday chart for JCR Pharmaceuticals Co., Ltd. -4.48% -47.18%
Apr. 25 JCR Pharmaceuticals Co., Ltd. Announces Management Changes, Effective as of June 26, 2024 CI
Mar. 21 US Fed Rate Outlook Catapults Japanese Shares to Fresh 52-Week Peak MT

Evolution of the average Target Price on JCR Pharmaceuticals Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

2c646e55e780736c3413b4abe1.WUR1wp0gco3tY_fxpCbYGCIhWn6AlOsfa_EJ1bfjmss.CSpFrvB2QOyGJrmJwXfuVnZRNTPMopNYPbhfsPyq4JgoGzKD6kIwv5QzlA~49096e98032e60c71df78e2eef4c0c8e

Analyst Recommendations on JCR Pharmaceuticals Co., Ltd.

Jefferies Adjusts JCR Pharmaceuticals’ Price Target to 1,200 Yen From 1,400 Yen, Keeps at Hold MT
Jefferies Adjusts JCR Pharmaceuticals’ Price Target to 1,400 Yen From 1,360 Yen, Keeps at Hold MT
Jefferies Adjusts JCR Pharmaceuticals’ Price Target to 1,360 Yen From 1,200 Yen, Keeps at Hold MT
Jefferies Downgrades JCR Pharmaceuticals to Hold From Buy, Adjusts Price Target to 1,200 Yen From 1,800 Yen MT
Jefferies Adjusts JCR Pharmaceuticals to 1,800 Yen From 2,300 Yen, Keeps at Buy MT
Jefferies Adjusts JCR Pharmaceuticals' Price Target to 2,300 Yen From 3,900 Yen, Keeps at Buy MT
Japan Index Witnesses Strong Buying; Shares of Sysmex, JCR Pharmaceuticals Expand 4% on Regenerative Medicine JV MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
619 JPY
Average target price
1,557 JPY
Spread / Average Target
+151.56%
High Price Target
2,000 JPY
Spread / Highest target
+223.10%
Low Price Target
1,200 JPY
Spread / Lowest Target
+93.86%

Consensus detail

Consensus revision (last 18 months)

Analysts covering JCR Pharmaceuticals Co., Ltd.

Jefferies & Co.
Nomura

Ratings for JCR Pharmaceuticals Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 4552 Stock
  4. Consensus JCR Pharmaceuticals Co., Ltd.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW